FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of
--------------------------
1934
----
November 27, 2002
Commission File Number 001-14978
SMITH & NEPHEW plc
(Registrant's name)
15 Adam Street
London, England WC2N 6LA
(Address of registrant's principal executive offices)
[Indicate by check mark whether the registrant files or will file
annual reports under cover Form 20-F or Form 40-F.]
Form 20-F X Form 40-F
------- ------
[Indicate by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(1).]
Yes No X
------- ------
[Indicate by check mark if the registrant is submitting the Form 6-K in paper as
permitted by Regulation S-T Rule 101(b)(7).]
Yes No X
------- -------
[Indicate by check mark whether by furnishing the information contained
in this Form, the registrant is also thereby furnishing information to the
Commission pursuant to Rule 12g3-2 (b) under the Securities Exchange Act of
1934.]
Yes No X
------- ------
If "Yes" is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2 (b) : 82- n/a.
Total Pages: 4
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Smith & Nephew plc
(Registrant)
Date: November 27, 2002 By: /s/ Paul Chambers
-------------------
Paul Chambers
Company Secretary
2
25 November 2002
Completion of Dermagraft Acquisition
Smith & Nephew, the global advanced medical devices company, announces that it
has completed the $12 million acquisition of the Dermagraft(R) and TransCyte(R)
joint venture from Advanced Tissue Sciences, Inc.
Enquiries:
Christopher O'Donnell, Chief Executive Tel: +44 (0) 20 7401 7646
Smith & Nephew plc
Peter Hooley, Finance Director Tel: +44 (0) 20 7401 7646
Smith & Nephew plc
Angie Craig, Corporate Affairs Director Tel: +44 (0) 20 7401 7646
Smith & Nephew plc
David Yates/Jonathan Birt Tel: +44 (0) 20 7831 3113
Financial Dynamics
25 November 2002
The Secretary
London Stock Exchange
RNS
Old Broad Street
London
EC2N 1HP
Dear Sirs,
Dealing by Director in Ordinary shares of Smith & Nephew plc
We have been informed today that Dudley Eustace, a director of Smith & Nephew
plc, has acquired 195 Ordinary shares of the Company at 383.23 pence each on 22
November 2002, through the re-investment of the final dividend paid on 15
November 2002. Mr. Eustace now has a beneficial interest in 49,679 Ordinary
shares being 0.0054% of the issued share capital of the Company.
Yours faithfully,
J.V. Sutton
Assistant Company Secretary